MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Exploring Pallidothalamotractotomy as an Option for Management of Refractory Dystonia following Failure of Pallidotomy

A. Adhya, D. Garg, D. Radhakrishnan, A. Das, E. Arun, R. Rajan, A. Garg, A. Srivastava, K. Garg (New Delhi, India)

Meeting: 2025 International Congress

Keywords: Dystonia: Treatment, Pallidotomy

Category: Dystonia: Medical Therapy / Surgical Therapy

Objective: To assess the efficacy and safety of PTT as a rescue procedure after pallidotomy in two patients with refractory dystonia.

Background: In cases of severe or treatment-refractory dystonia, surgical management options include lesioning surgeries or neuromodulation, such as Deep Brain Stimulation (DBS). Recently, interest in Pallidothalamotractotomy (PTT) has resurfaced as a potential salvage therapy for refractory dystonia following failure of pallidotomy.

Method: This single-center case series analyzed two patients who underwent unilateral PTT for worsening dystonia post-pallidotomy at a tertiary movement disorders center. The Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) was used to assess pre- and post-operative severity and disability.

Results: Two males with idiopathic dystonia underwent unilateral PTT (Table 1). The symptom duration before pallidotomy was 8 and 2 years respectively, and the interval between pallidotomy and PTT was 59 and 70 months. Both patients had undergone prior bilateral pallidotomy. The BFMDRS motor score for case 1 improved from 36 pre-PTT to 11.5 immediately post-PTT and then to 10, which was sustained till last follow up at six months (Table 2). However, he had worsening of post-operative dysarthria albeit without functional decline. Case 2 showed improvement from 20 pre-PTT to 9.5 immediately post-PTT and 10 at 3 months. The improvement was sustained for 10 months before he had worsening due to cervical compressive myeloneuropathy. He experienced no adverse effects after PTT.

Conclusion: Unilateral PTT may serve as a rescue treatment for refractory dystonia following failure of pallidotomy. While initial outcomes suggest benefit, larger studies are needed to validate long-term efficacy and safety.

Table 1

Table 1

Table 2

Table 2

To cite this abstract in AMA style:

A. Adhya, D. Garg, D. Radhakrishnan, A. Das, E. Arun, R. Rajan, A. Garg, A. Srivastava, K. Garg. Exploring Pallidothalamotractotomy as an Option for Management of Refractory Dystonia following Failure of Pallidotomy [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/exploring-pallidothalamotractotomy-as-an-option-for-management-of-refractory-dystonia-following-failure-of-pallidotomy/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/exploring-pallidothalamotractotomy-as-an-option-for-management-of-refractory-dystonia-following-failure-of-pallidotomy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley